Dr. Jones gained his PhD at the Sanger Institute, Cambridge, UK in 1999, where he was involved in the C. elegans genome project. Currently, he is Head of Bioinformatics and Associate Director of the Genome Sciences Centre at the BC Cancer Agency in Vancouver. Dr Jones has played a role in numerous other genome projects, including that of the human, mouse, rat, bovine, fruitfly and the SARS coronavirus.
Dr Jones major research focus is in the computational analysis of DNA sequence and the analysis of genomic and transcriptomic data. In healthcare research, he has applied next generation DNA sequencing technology to detect mutations arising in both patient samples and in cancer cell lines in various cancer types and under the influence of different therapeutics. A key goal is to develop bioinformatic approaches to predict the most efficacious therapies from patient tumour samples to help guide clinical decision making.
Amongst Dr. Jones many and varied honours and awards he is a Fellow of the Royal Society of Canada as well as the Canadian Academy of Health Sciences.
He has been invited to give over 120 presentations, nationally and internationally, is an author on over 300 peer reviewed publications and is Principal Investigator and co-applicant on grants totaling over $97 million.
- Head of Bioinformatics, Associate Director, Michael Smith Genome Sciences Centre
British Columbia Cancer Research Centre
Vancouver, BC, Canada